{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:02:12Z","timestamp":1793908932400,"version":"4.8.0"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.neuropharm.2020.108359","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T13:06:28Z","timestamp":1603112788000},"page":"108359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse"],"prefix":"10.1016","volume":"183","author":[{"given":"Morgan H.","family":"James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Fragale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayna L.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Aston-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108359_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12640-020-00196-y","article-title":"The effect of orexin receptor antagonism on quinpirole-induced compulsive-like checking behavior in rats","volume":"38","author":"Abounoori","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib2","doi-asserted-by":"crossref","first-page":"145942","DOI":"10.1016\/j.brainres.2018.09.010","article-title":"Role of medial hypothalamic orexin system in panic, phobia and hypertension","volume":"1731","author":"Abreu","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","article-title":"Modafinil for the treatment of cocaine dependence","volume":"104","author":"Anderson","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2020.108359_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1300\/J069v16n03_08","article-title":"Cocaethylene toxicity","volume":"16","author":"Andrews","year":"1997","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.neuropharm.2020.108359_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.drugalcdep.2014.07.025","article-title":"Correlates of polysomnographic sleep changes in cocaine dependence: self-administration and clinical outcomes","volume":"143","author":"Angarita","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2020.108359_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.drugalcdep.2013.11.007","article-title":"Abstinence-related changes in sleep during treatment for cocaine dependence","volume":"134","author":"Angarita","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2020.108359_bib7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1037\/1064-1297.2.3.244","article-title":"Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey","volume":"2","author":"Anthony","year":"1994","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.108359_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.psyneuen.2013.10.010","article-title":"Anxiolytic function of the orexin 2\/hypocretin A receptor in the basolateral amygdala","volume":"40","author":"Arendt","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2020.108359_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1037\/a0031442","article-title":"Depressive behavior and activation of the orexin\/hypocretin system","volume":"127","author":"Arendt","year":"2013","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s002130050232","article-title":"Ethanol effects on self-administration of alfentanil, cocaine, and nomifensine in rhesus monkeys","volume":"130","author":"Aspen","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108359_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF00432019","article-title":"Cocaine antagonizes anxiolytic effects of ethanol","volume":"84","author":"Aston-Jones","year":"1984","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108359_bib12","doi-asserted-by":"crossref","first-page":"145915","DOI":"10.1016\/j.brainres.2018.08.018","article-title":"Orexin\/hypocretin and dysregulated eating: promotion of foraging behavior","volume":"1731","author":"Barson","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/adb.12139","article-title":"Anterior thalamic paraventricular nucleus is involved in intermittent access ethanol drinking: role of orexin receptor 2","volume":"20","author":"Barson","year":"2015","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/adb.12288","article-title":"Substance P in the anterior thalamic paraventricular nucleus: promotion of ethanol drinking in response to orexin from the hypothalamus","volume":"22","author":"Barson","year":"2017","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neuropharm.2014.09.012","article-title":"Both Ox1r and Ox2r orexin receptors contribute to the cardiovascular and locomotor components of the novelty stress response in the rat","volume":"89","author":"Beig","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108359_bib16","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/ejn.12866","article-title":"Orexin-1 receptor signaling increases motivation for cocaine-associated cues","volume":"41","author":"Bentzley","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00213-012-2899-2","article-title":"The behavioral economics of drug self-administration: a review and new analytical approach for within-session procedures","volume":"226","author":"Bentzley","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108359_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2009.09.019","article-title":"Hypocretin\/orexin in arousal and stress","volume":"1314","author":"Berridge","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuroscience.2018.04.005","article-title":"Sex- and age-dependent effects of orexin 1 receptor blockade on open-field behavior and neuronal activity","volume":"381","author":"Blume","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108359_bib20","doi-asserted-by":"crossref","first-page":"11215","DOI":"10.1523\/JNEUROSCI.6096-08.2009","article-title":"Orexin A\/hypocretin-1 selectively promotes motivation for positive reinforcers","volume":"29","author":"Borgland","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib21","doi-asserted-by":"crossref","first-page":"19168","DOI":"10.1073\/pnas.0507480102","article-title":"Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior","volume":"102","author":"Boutrel","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.108359_bib22","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/da.22635","article-title":"New directions for the treatment of depression: targeting the photic regulation of arousal and mood (PRAM) pathway","volume":"34","author":"Bowrey","year":"2017","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.neuropharm.2020.108359_bib23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1471-4159.1993.tb03305.x","article-title":"Cocaine and cocaethylene: microdialysis comparison of brain drug levels and effects on dopamine and serotonin","volume":"60","author":"Bradberry","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108359_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/19371918.2013.774675","article-title":"Substance use disorders and anxiety: a treatment challenge for social workers","volume":"28","author":"Brady","year":"2013","journal-title":"Soc. Work. Publ. Health"},{"key":"10.1016\/j.neuropharm.2020.108359_bib26","doi-asserted-by":"crossref","first-page":"145894","DOI":"10.1016\/j.brainres.2018.07.027","article-title":"Hypocretin receptor 1 involvement in cocaine-associated behavior: therapeutic potential and novel mechanistic insights","volume":"1731","author":"Brodnik","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib27","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0196-0644(96)70266-4","article-title":"Coacaethylene levels in patients who test positive for cocaine","volume":"27","author":"Brookoff","year":"1996","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2020.108359_bib28","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1017\/S1461145713000333","article-title":"Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats","volume":"16","author":"Brown","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.euroneuro.2007.01.005","article-title":"Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder","volume":"17","author":"Brundin","year":"2007","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.108359_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2006.10.019","article-title":"Orexin and psychiatric symptoms in suicide attempters","volume":"100","author":"Brundin","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2020.108359_bib31","doi-asserted-by":"crossref","first-page":"145943","DOI":"10.1016\/j.brainres.2018.09.011","article-title":"How orexin signals bias action: hypothalamic and accumbal circuits","volume":"1731","author":"Burdakov","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.physbeh.2013.03.023","article-title":"Lateral hypothalamus as a sensor-regulator in respiratory and metabolic control","volume":"121","author":"Burdakov","year":"2013","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2020.108359_bib33","doi-asserted-by":"crossref","first-page":"145902","DOI":"10.1016\/j.brainres.2018.08.005","article-title":"A sleeping giant: suvorexant for the treatment of alcohol use disorder?","volume":"1731","author":"Campbell","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib34","doi-asserted-by":"crossref","first-page":"146597","DOI":"10.1016\/j.brainres.2019.146597","article-title":"Suvorexant to treat alcohol use disorder and comorbid insomnia: plan for a phase II trial","volume":"1728","author":"Campbell","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/7854_2016_46","article-title":"Orexin and central modulation of cardiovascular and respiratory function","volume":"33","author":"Carrive","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.neuropharm.2020.108359_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.psychres.2016.02.059","article-title":"Orexin-A level elevation in recently abstinent male methamphetamine abusers","volume":"239","author":"Chen","year":"2016","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2014.01.013","article-title":"Blocking of corticotrophin releasing factor receptor-1 during footshock attenuates context fear but not the upregulation of prepro-orexin mRNA in rats","volume":"120","author":"Chen","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108359_bib38","article-title":"Orexins (hypocretins) contribute to fear and avoidance in rats exposed to a single episode of footshocks","author":"Chen","year":"2013","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2020.108359_bib39","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/acer.14126","article-title":"Embryonic ethanol exposure affects the early development, migration, and location of hypocretin\/orexin neurons in zebrafish","volume":"43","author":"Collier","year":"2019","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib40","doi-asserted-by":"crossref","first-page":"109728","DOI":"10.1016\/j.pnpbp.2019.109728","article-title":"Maternal ethanol consumption before paternal fertilization: stimulation of hypocretin neurogenesis and ethanol intake in zebrafish offspring","volume":"96","author":"Collier","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2020.108359_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/YCO.0000000000000069","article-title":"Polysubstance use: diagnostic challenges, patterns of use and health","volume":"27","author":"Connor","year":"2014","journal-title":"Curr. Opin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108359_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00569","article-title":"One is not enough: understanding and modeling polysubstance use","volume":"14","author":"Crummy","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib43","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.drugalcdep.2015.05.016","article-title":"Effects of chronic binge-like ethanol consumption on cocaine self-administration in rhesus monkeys","volume":"153","author":"Czoty","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2020.108359_bib44","series-title":"Alcohol, Drugs, Genes and the Clinical Laboratory","first-page":"75","article-title":"4 - combined alcohol and drug abuse: a potentially deadly mix","author":"Dasgupta","year":"2017"},{"key":"10.1016\/j.neuropharm.2020.108359_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(99)00317-4","article-title":"Distribution of orexin\/hypocretin in the rat median eminence and pituitary","volume":"76","author":"Date","year":"2000","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuropharm.2020.108359_bib46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biopsych.2007.02.002","article-title":"Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse","volume":"63","author":"Dayas","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108359_bib47","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.108359_bib48","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1460-9568.2009.07065.x","article-title":"The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system","volume":"31","author":"Espana","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib49","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1523\/JNEUROSCI.21-05-01656.2001","article-title":"Fos expression in orexin neurons varies with behavioral state","volume":"21","author":"Estabrooke","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib50","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.tins.2015.06.005","article-title":"Orexins and fear: implications for the treatment of anxiety disorders","volume":"38","author":"Flores","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib51","article-title":"Intermittent self-administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system","author":"Fragale","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuropharm.2020.108359_bib52","series-title":"Intermittent self-administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system","author":"Fragale","year":"2020"},{"key":"10.1016\/j.neuropharm.2020.108359_bib53","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1038\/s41386-019-0420-x","article-title":"The role of orexin-1 receptor signaling in demand for the opioid fentanyl","volume":"44","author":"Fragale","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108359_bib54","article-title":"Sex differences in demand for highly palatable foods: role of the orexin system","author":"Freeman","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib55","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/j.1460-9568.2009.06952.x","article-title":"Hypocretin\/orexin contributes to the expression of some but not all forms of stress and arousal","volume":"30","author":"Furlong","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib56","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1523\/JNEUROSCI.23-08-03106.2003","article-title":"Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal","volume":"23","author":"Georgescu","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib57","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41593-018-0198-x","article-title":"Parallel circuits from the bed nuclei of stria terminalis to the lateral hypothalamus drive opposing emotional states","volume":"21","author":"Giardino","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2008.05.060","article-title":"Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity","volume":"1224","author":"Gompf","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib59","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1360-0443.2006.01497.x","article-title":"Concurrent use and order of use of cocaine and alcohol: behavioural differences between users of crack cocaine and cocaine powder","volume":"101","author":"Gossop","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2020.108359_bib60","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1038\/npp.2013.109","article-title":"Differential effect of orexin-1 and CRF-1 antagonism on stress circuits: a fMRI study in the rat with the pharmacological stressor Yohimbine","volume":"38","author":"Gozzi","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108359_bib61","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.yfrne.2018.06.003","article-title":"Orexins and stress","volume":"51","author":"Grafe","year":"2018","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib62","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.biopsych.2016.10.013","article-title":"Orexins mediate sex differences in the stress response and in cognitive flexibility","volume":"81","author":"Grafe","year":"2017","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108359_bib63","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0273-17.2018","article-title":"Reduced orexin system function contributes to resilience to repeated social stress","volume":"5","author":"Grafe","year":"2018","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2020.108359_bib64","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neuroscience.2017.02.038","article-title":"Orexin 2 receptor regulation of the hypothalamic-pituitary-adrenal (HPA) response to acute and repeated stress","volume":"348","author":"Grafe","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108359_bib65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0376-8716(90)90147-7","article-title":"Concurrent and simultaneous use of alcohol with cocaine: results of national survey","volume":"25","author":"Grant","year":"1990","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2020.108359_bib66","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neuroscience.2007.01.063","article-title":"The neural correlates and role of D1 dopamine receptors in renewal of extinguished alcohol-seeking","volume":"146","author":"Hamlin","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108359_bib67","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.tins.2006.08.002","article-title":"Arousal and reward: a dichotomy in orexin function","volume":"29","author":"Harris","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib68","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature04071","article-title":"A role for lateral hypothalamic orexin neurons in reward seeking","volume":"437","author":"Harris","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.108359_bib69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s002139900363","article-title":"Comparison of intravenous cocaethylene and cocaine in humans","volume":"149","author":"Hart","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108359_bib70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-0115(00)00199-3","article-title":"A selective orexin-1 receptor antagonist reduces food consumption in male and female rats","volume":"96","author":"Haynes","year":"2000","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2020.108359_bib71","article-title":"Optogenetic examination identifies a context-specific role for orexins\/hypocretins in anxiety-related behavior","author":"Heydendael","year":"2013","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2020.108359_bib72","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02244943","article-title":"Acute behavioral and cardiac effects of cocaine and alcohol combinations in humans","volume":"111","author":"Higgins","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108359_bib73","doi-asserted-by":"crossref","first-page":"108013","DOI":"10.1016\/j.neuropharm.2020.108013","article-title":"Recent perspectives on orexin\/hypocretin promotion of addiction-related behaviors","volume":"168","author":"Hopf","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108359_bib74","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.biopsych.2017.01.010","article-title":"Orexin\/hypocretin, central amygdala, and escalation of cocaine intake","volume":"81","author":"James","year":"2017","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108359_bib75","doi-asserted-by":"crossref","first-page":"146665","DOI":"10.1016\/j.brainres.2020.146665","article-title":"Introduction to the Special Issue: \"Making orexin-based therapies for addiction a reality: what are the steps from here?","volume":"1731","author":"James","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib77","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1111\/ejn.14166","article-title":"Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin\/hypocretin-1 receptor antagonist in rats","volume":"50","author":"James","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/7854_2016_56","article-title":"Role of the orexin\/hypocretin system in stress-related psychiatric disorders","volume":"33","author":"James","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.neuropharm.2020.108359_bib79","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fnbeh.2014.00244","article-title":"Exercise reverses the effects of early life stress on orexin cell reactivity in male but not female rats","volume":"8","author":"James","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib80","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1017\/S1461145711000423","article-title":"Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking","volume":"14","author":"James","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-020-0619-x","article-title":"Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?","author":"James","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108359_bib82","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/7854_2016_57","article-title":"A decade of orexin\/hypocretin and addiction: where are we now?","volume":"33","author":"James","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.neuropharm.2020.108359_bib84","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.biopsych.2018.07.022","article-title":"Increased number and activity of a lateral subpopulation of hypothalamic orexin\/hypocretin neurons underlies the expression of an addicted state in rats","volume":"85","author":"James","year":"2019","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108359_bib85","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/0024-3205(91)90217-Y","article-title":"Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion","volume":"48","author":"Jatlow","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib86","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.physbeh.2012.04.016","article-title":"Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network","volume":"107","author":"Johnson","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2020.108359_bib87","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainres.2011.03.045","article-title":"The orexin(1) receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats","volume":"1391","author":"Jupp","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib88","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuropharm.2016.07.006","article-title":"Nucleus incertus Orexin2 receptors mediate alcohol seeking in rats","volume":"110","author":"Kastman","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108359_bib89","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1007\/s00213-016-4393-8","article-title":"Less is more: prolonged intermittent access cocaine self-administration produces incentive-sensitization and addiction-like behavior","volume":"233","author":"Kawa","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108359_bib90","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1747-597X-2-33","article-title":"Mono- versus polydrug abuse patterns among publicly funded clients","volume":"2","author":"Kedia","year":"2007","journal-title":"Subst. Abuse Treat. Prev. Pol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib91","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpsychires.2020.05.025","article-title":"Lemborexant vs suvorexant for insomnia: a systematic review and network meta-analysis","volume":"128","author":"Kishi","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib92","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pbb.2006.08.012","article-title":"Alcohol consumption is preferred to water in rats pretreated with intravenous cocaine","volume":"85","author":"Knackstedt","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108359_bib93","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0091-3057(02)00764-5","article-title":"Evidence for opponent-process actions of intravenous cocaine and cocaethylene","volume":"72","author":"Knackstedt","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2020.108359_bib94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4088\/JCP.13011su1c","article-title":"Understanding the sleep-wake cycle: sleep, insomnia, and the orexin system","volume":"74","author":"Krystal","year":"2013","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108359_bib95","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0167-0115(01)00340-8","article-title":"Effects of restricted feeding on the activity of hypothalamic Orexin (OX)-A containing neurons and OX2 receptor mRNA level in the paraventricular nucleus of rats","volume":"104","author":"Kurose","year":"2002","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2020.108359_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036871","article-title":"Hypothalamic orexin--a neurons are involved in the response of the brain stress system to morphine withdrawal","volume":"7","author":"Laorden","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2020.108359_bib97","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.bjp.0706789","article-title":"The orexin system regulates alcohol-seeking in rats","volume":"148","author":"Lawrence","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib98","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fnins.2019.00088","article-title":"Nucleus accumbens shell orexin-1 receptors are critical mediators of binge intake in excessive-drinking individuals","volume":"13","author":"Lei","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib99","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.neuropharm.2016.08.008","article-title":"Orexin-1 receptor blockade suppresses compulsive-like alcohol drinking in mice","volume":"110","author":"Lei","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108359_bib100","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fnins.2016.00400","article-title":"Nucleus accumbens shell and mPFC but not insula orexin-1 receptors promote excessive alcohol drinking","volume":"10","author":"Lei","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib101","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1901\/jeab.1994.61-223","article-title":"Synergistic effects of ethanol and cocaine on brain stimulation reward","volume":"61","author":"Lewis","year":"1994","journal-title":"J. Exp. Anal. Behav."},{"key":"10.1016\/j.neuropharm.2020.108359_bib102","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/7854_2016_58","article-title":"Hypocretins and arousal","volume":"33","author":"Li","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.neuropharm.2020.108359_bib103","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00213-010-1948-y","article-title":"Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats","volume":"212","author":"Li","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108359_bib104","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.physbeh.2010.10.006","article-title":"Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal","volume":"102","author":"Li","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2020.108359_bib105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.drugalcdep.2018.07.025","article-title":"The importance of considering polysubstance use: lessons from cocaine research","volume":"192","author":"Liu","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2020.108359_bib106","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1210\/endo.140.12.7287","article-title":"Orexin receptors are expressed in the adrenal medulla of the rat","volume":"140","author":"Lo Pez","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2020.108359_bib107","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(01)01569-5","article-title":"Prepro-orexin mRNA levels in the rat hypothalamus, and orexin receptors mRNA levels in the rat hypothalamus and adrenal gland are not influenced by the thyroid status","volume":"300","author":"L\u00f3pez","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2020.108359_bib108","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1523\/JNEUROSCI.5584-07.2008","article-title":"Orexin signaling mediates the antidepressant-like effect of calorie restriction","volume":"28","author":"Lutter","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib109","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neulet.2013.07.010","article-title":"The influence of orexins on ethanol-induced behavioral sensitization in male mice","volume":"551","author":"Macedo","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2020.108359_bib110","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nn.3810","article-title":"Motivational activation: a unifying hypothesis of orexin\/hypocretin function","volume":"17","author":"Mahler","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib111","first-page":"713","article-title":"Effects of orexins A and B on the secretory and proliferative activity of immature and regenerating rat adrenal glands","volume":"16","author":"Malendowicz","year":"2001","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib112","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cne.1190","article-title":"Differential expression of orexin receptors 1 and 2 in the rat brain","volume":"435","author":"Marcus","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib113","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/adb.12441","article-title":"Differential role of hypothalamic orexin\/hypocretin neurons in reward seeking motivated by cocaine versus palatable food","volume":"23","author":"Martin-Fardon","year":"2018","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib114","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1369-1600.2012.00480.x","article-title":"N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-yl urea (SB334867), a hypocretin receptor-1 antagonist, preferentially prevents ethanol seeking: comparison with natural reward seeking","volume":"19","author":"Martin-Fardon","year":"2014","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.regpep.2003.10.003","article-title":"Increased hypocretin-1 (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity","volume":"117","author":"Martins","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2020.108359_bib116","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0741-8329(89)90015-3","article-title":"Increased stimulatory effect by the combined administration of cocaine and alcohol in mice","volume":"6","author":"Masur","year":"1989","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2020.108359_bib117","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/jpet.116.235945","article-title":"Orexin-A\/Hypocretin-1 mediates cocaine-seeking behavior in the posterior paraventricular nucleus of the thalamus via orexin\/hypocretin receptor-2","volume":"359","author":"Matzeu","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108359_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10040226","article-title":"Targeting the orexin system for prescription opioid use disorder","volume":"10","author":"Matzeu","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib119","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-3565(25)10557-0","article-title":"Cocaethylene: pharmacology, physiology and behavioral effects in humans","volume":"274","author":"McCance","year":"1995","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108359_bib120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02257405","article-title":"Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene","volume":"111","author":"McCance-Katz","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108359_bib121","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0255-19.2019","article-title":"Orexin-1 receptor signaling in ventral pallidum regulates motivation for the opioid remifentanil","author":"Mohammadkhani","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib122","first-page":"146461","article-title":"Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil","author":"Mohammadkhani","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib123","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00213-018-4871-2","article-title":"The hypocretin\/orexin system as a target for excessive motivation in alcohol use disorders","volume":"235","author":"Moorman","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108359_bib124","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/ejn.13170","article-title":"Orexin\/hypocretin neuron activation is correlated with alcohol seeking and preference in a topographically specific manner","volume":"43","author":"Moorman","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2016.10.018","article-title":"Orexin\/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats","volume":"1654","author":"Moorman","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib126","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1530-0277.2010.01161.x","article-title":"Differential effects of acute and chronic ethanol exposure on orexin expression in the perifornical lateral hypothalamus","volume":"34","author":"Morganstern","year":"2010","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib127","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF02245328","article-title":"Differences in bioavailability between cocaine and cocaethylene and their implications for drug-reward studies","volume":"116","author":"Nobiletti","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108359_bib128","article-title":"The dual orexin\/hypocretin receptor antagonist suvorexant reduces addiction-like behaviors for the opioid fentanyl","author":"O'Connor","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuropharm.2020.108359_bib129","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/acer.13336","article-title":"The role of orexin signaling in the ventral tegmental area and central amygdala in modulating binge-like ethanol drinking behavior","volume":"41","author":"Olney","year":"2017","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib130","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1021\/js990184j","article-title":"Cocaine and alcohol interactions in the rat: effect of cocaine and alcohol pretreatments on cocaine pharmacokinetics and pharmacodynamics","volume":"88","author":"Pan","year":"1999","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.neuropharm.2020.108359_bib131","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pbb.2011.12.011","article-title":"Evidence for a role of inhibition of orexinergic neurons in the anxiolytic and sedative effects of diazepam: a c-Fos study","volume":"101","author":"Panhelainen","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108359_bib132","series-title":"The Number of Lateral Hypothalamus Orexin\/hypocretin Neurons Contributes to Individual Differences in Cocaine Demand","first-page":"547836","author":"Pantazis","year":"2019"},{"key":"10.1016\/j.neuropharm.2020.108359_bib133","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12795","article-title":"The number of lateral hypothalamus orexin\/hypocretin neurons contributes to individual differences in cocaine demand","volume":"25","author":"Pantazis","year":"2020","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib134","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib135","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1523\/JNEUROSCI.5724-09.2010","article-title":"Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior","volume":"30","author":"Plaza-Zabala","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib136","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1021\/cn500246j","article-title":"Hypocretin\/Orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1","volume":"6","author":"Prince","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib137","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1021\/cn500246j","article-title":"Hypocretin\/orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1","volume":"6","author":"Prince","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib138","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1037\/1064-1297.8.1.117","article-title":"Comparison of the reinforcing and anxiogenic effects of intravenous cocaine and cocaethylene","volume":"8","author":"Raven","year":"2000","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.108359_bib139","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00213-008-1136-5","article-title":"Inhibition of orexin-1\/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats","volume":"199","author":"Richards","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108359_bib140","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.2820058","article-title":"Cocaine receptors on dopamine transporters are related to self-administration of cocaine","volume":"237","author":"Ritz","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108359_bib141","doi-asserted-by":"crossref","DOI":"10.1002\/npr2.12117","article-title":"Current and potential pharmacological treatment options for insomnia in patients with alcohol use disorder in recovery","author":"Roehrs","year":"2020","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.neuropharm.2020.108359_bib142","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archpsyc.1991.01810250045005","article-title":"Psychiatric diagnoses of treatment-seeking cocaine abusers","volume":"48","author":"Rounsaville","year":"1991","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108359_bib143","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.regpep.2003.12.014","article-title":"Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons","volume":"118","author":"Sakamoto","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2020.108359_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2020.108359_bib145","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.tips.2011.03.007","article-title":"Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal","volume":"32","author":"Sakurai","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib146","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuron.2005.03.010","article-title":"Input of orexin\/hypocretin neurons revealed by a genetically encoded tracer in mice","volume":"46","author":"Sakurai","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108359_bib147","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.biopsych.2016.06.010","article-title":"Hypocretin neurotransmission within the central amygdala mediates escalated cocaine self-administration and stress-induced reinstatement in rats","volume":"81","author":"Schmeichel","year":"2017","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108359_bib148","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.biopsych.2016.06.010","article-title":"Hypocretin neurotransmission within the central amygdala mediates escalated cocaine self-administration and stress-induced reinstatement in rats","volume":"81","author":"Schmeichel","year":"2017","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108359_bib149","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-018-0054-4","article-title":"Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats","author":"Schmeichel","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108359_bib150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-010-2127-x","article-title":"Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement","volume":"215","author":"Shoblock","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2020.108359_bib151","article-title":"Cocaine abuse and midbrain circuits: functional anatomy of hypocretin\/orexin transmission and therapeutic prospect","author":"Simmons","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib152","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1460-9568.2009.06844.x","article-title":"Orexin\/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking","volume":"30","author":"Smith","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib153","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1460-9568.2009.06844.x","article-title":"Orexin\/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking","volume":"30","author":"Smith","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib154","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neuropharm.2009.06.042","article-title":"Orexin\/hypocretin is necessary for context-driven cocaine-seeking","volume":"58","author":"Smith","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108359_bib155","doi-asserted-by":"crossref","first-page":"146037","DOI":"10.1016\/j.brainres.2018.11.032","article-title":"Orexin as a modulator of fear-related behavior: hypothalamic control of noradrenaline circuit","volume":"1731","author":"Soya","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib156","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044726","article-title":"The dual orexin\/hypocretin receptor antagonist, almorexant, in the ventral tegmental area attenuates ethanol self-administration","volume":"7","author":"Srinivasan","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2020.108359_bib157","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.yhbeh.2013.12.014","article-title":"The orexin-1 receptor antagonist SB-334867 attenuates anxiety in rats exposed to cat odor but not the elevated plus maze: an investigation of Trial 1 and Trial 2 effects","volume":"65","author":"Staples","year":"2014","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2020.108359_bib158","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuropharm.2018.09.016","article-title":"Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression","volume":"143","author":"Staton","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108359_bib159","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbr.2014.09.024","article-title":"Model of voluntary ethanol intake in zebrafish: effect on behavior and hypothalamic orexigenic peptides","volume":"278","author":"Sterling","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib160","first-page":"146359","article-title":"Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder","author":"Suchting","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib161","doi-asserted-by":"crossref","first-page":"146085","DOI":"10.1016\/j.brainres.2018.12.036","article-title":"Orexin\/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: potential for therapy","volume":"1731","author":"Summers","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib162","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/0269881115609015","article-title":"Psychomotor effects, pharmacokinetics and safety of the orexin receptor antagonist suvorexant administered in combination with alcohol in healthy subjects","volume":"29","author":"Sun","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib163","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnbeh.2013.00028","article-title":"Role of orexin in modulating arousal, feeding, and motivation","volume":"7","author":"Tsujino","year":"2013","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib164","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bbr.2014.10.028","article-title":"The orexin-1 receptor antagonist SB-334867 decreases anxiety-like behavior and c-Fos expression in the hypothalamus of rats exposed to cat odor","volume":"278","author":"Vanderhaven","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib165","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s000180300005","article-title":"Orexins and their receptors: structural aspects and role in peripheral tissues","volume":"60","author":"Voisin","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib166","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/7854_2016_55","article-title":"The role of orexins\/hypocretins in alcohol use and abuse","volume":"33","author":"Walker","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.neuropharm.2020.108359_bib167","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.biopsych.2009.01.018","article-title":"Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network","volume":"65","author":"Wang","year":"2009","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108359_bib168","doi-asserted-by":"crossref","first-page":"11439","DOI":"10.1523\/JNEUROSCI.3459-04.2004","article-title":"Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response","volume":"24","author":"Winsky-Sommerer","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib169","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1006\/bbrc.2001.6318","article-title":"Orexins activate histaminergic neurons via the orexin 2 receptor","volume":"290","author":"Yamanaka","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2020.108359_bib170","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1365-2826.2010.02015.x","article-title":"New approaches for the study of orexin function","volume":"22","author":"Yamanaka","year":"2010","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib171","doi-asserted-by":"crossref","first-page":"112365","DOI":"10.1016\/j.bbr.2019.112365","article-title":"The role of the nucleus accumbens OXR1 in cocaine-induced locomotor sensitization","volume":"379","author":"Yang","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108359_bib172","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fnins.2014.00036","article-title":"Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls","volume":"8","author":"Yeoh","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib173","article-title":"Activation of lateral hypothalamic group III metabotropic glutamate receptors suppresses cocaine-seeking following abstinence and normalizes drug-associated increases in excitatory drive to orexin\/hypocretin cells","author":"Yeoh","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108359_bib174","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/cne.20859","article-title":"Afferents to the orexin neurons of the rat brain","volume":"494","author":"Yoshida","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108359_bib175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fnbeh.2017.00083","article-title":"Selective inhibition of orexin-2 receptors prevents stress-induced ACTH release in mice","volume":"11","author":"Yun","year":"2017","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108359_bib176","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.neuroscience.2008.03.023","article-title":"Effects of cocaine place conditioning, chronic escalating-dose \"binge\" pattern cocaine administration and acute withdrawal on orexin\/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague-Dawley rats","volume":"153","author":"Zhou","year":"2008","journal-title":"Neuroscience"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820304275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820304275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:07:49Z","timestamp":1758438469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820304275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":173,"alternative-id":["S0028390820304275"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108359","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108359"}}